+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "DDAVP"

Nocturia - Pipeline Insight, 2024 - Product Thumbnail Image

Nocturia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Desmopressin acetate (DDAVP) is a synthetic form of the natural hormone arginine vasopressin, used to treat a variety of endocrine and metabolic disorders. It is used to treat diabetes insipidus, a condition in which the body does not produce enough antidiuretic hormone, resulting in excessive urination and dehydration. It is also used to treat von Willebrand disease, a bleeding disorder caused by a deficiency of von Willebrand factor. DDAVP is also used to treat certain types of hemophilia, as well as to reduce bleeding during certain medical procedures. DDAVP is available in a variety of forms, including tablets, nasal sprays, and injectable solutions. It is typically administered as a single dose, although multiple doses may be required in some cases. The drug is generally well tolerated, with few side effects reported. Companies in the DDAVP market include Novo Nordisk, Pfizer, Sanofi, and Ferring Pharmaceuticals. Show Less Read more